Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-21

Clinical Trial Update: A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial by Adocia evaluates the pharmacokinetics, pharmacodynamics, safety, and tolerability of BioChaperone Pramlintide Insulin in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioChaperone Pramlintide Insulin

Snippet

Sponsor: Adocia | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED